换一批
换一批Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.
作者：
主题词
抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);人类(Humans);肿瘤(Neoplasms);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);西罗莫司(Sirolimus);ras蛋白质类(ras Proteins)
DOI
10.1634/theoncologist.2013-0335
PMID
24674875
发布时间
2021-10-21
- 浏览12
The oncologist
344-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
